Medical Marijuana, Inc. CEO Stuart Titus was featured by Forbes this week, explaining Kannalife™ Sciences role in developing a pharmaceutical treatment for Chronic Traumatic Encephalopathy (CTE). CTE is a degenerative brain disorder caused by repeated brain trauma, which has shown to be pervasive amongst NFL players in recent years.
Read the article below, or at its original source here.
